logo

For the Inventor, By the Inventor

West Chester, PA, United States of America

Michael E Lewis

This inventor holds 20 USPTO granted patents and 3 published patent applications, primarily in Neurological Disorders. Top assignees: Cephalon, Inc., Kyowa Hakko Kogyo Co., Ltd., Albert Einstein College of Medicine. Active years: 1992-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael E Lewis. Retrieved from https://idiyas.com/inventor/michael-e-lewis

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 20 

% Patents Active = 100.0

Average Co-Inventor Count = 3.7

ph-index = 11

Forward Citations = 440(Granted Patents)


Location History:

  • Landenberg, PA (US) (1992 - 1995)
  • Santa Rosa, CA (US) (1995)
  • Hartville, OH (US) (2000)
  • West Chester, PA (US) (1995 - 2012)

Company Filing History:

goldMedal16 out of 248 
 
Cephalon, Inc.
 patents
silverMedal4 out of 730 
 
Kyowa Hakko Kogyo Co., Ltd.
 patents
bronzeMedal3 out of 514 
 
Albert Einstein College of Medicine
 patents
4. 1 out of 31 
 
Cara Therapeutics, Inc.
 patents
5. 1 out of 9 
 
Kyowa Hakko Kogyo
 patents
6. 3 out of 834,570 
Other
 patents
where one patent can have more than one assignee

Years Active: 1992-2012

Loading Chart...
Areas of Expertise:
Protein Kinase Inhibitors
Insulin-Like Growth Factors
Neurological Disorders
Peripheral Neuropathy
K-252a Derivatives
Oxidation Prevention
Retinal Neuronal Disorders
Mammalian Prolactin
20 patents (USPTO):Explore Patents
1. 8217000 - Method for elevating prolactin in mammals (2012-07-10),
2. 6723699 - Treating disorders by application of insulin-like growth factors and analogs (2004-04-20),
3. 6693076 - Treating disorders by application of insulin-like growth factors and analogs (2004-02-17),
4. 6310040 - Treating retinal neuronal disorders by the application of insulin-like growth factors and analogs (2001-10-30),
5. 6046515 - Process and apparatus for preventing oxidation of metal (2000-04-04),
6. 5776897 - Treating disorders by application of insulin-like growth factors and (1998-07-07),
7. 5756494 - Protein kinase inhibitors for treatment of neurological disorders (1998-05-26),
8. 5741808 - Protein kinase inhibitors for treatmen of neurological disorders (1998-04-21),
9. 5703045 - Treating disorders by application of insulin-like growth factors and (1997-12-30),
10. 5652214 - Treating disorders by application of insulin-like growth factors and (1997-07-29),
11. 5648335 - Prevention and treatment of peripheral neuropathy (1997-07-15),
12. 5633228 - Prevention and treatment of peripheral neuropathy (1997-05-27),
13. 5621101 - Protein kinase inhibitors for treatment of neurological disorders (1997-04-15),
14. 5621100 - K-252a derivatives for treatment of neurological disorders (1997-04-15),
15. 5569648 - Prevention and treatment of peripheral neuropathy (1996-10-29),

Title: The Inventor Michael E Lewis: Pioneering Innovations in West Chester, PA

Introduction: Michael E Lewis is a renowned inventor based in West Chester, PA, known for his groundbreaking contributions to various industries.

Latest Patents: Michael E Lewis holds several patents in the fields of technology, healthcare, and consumer products, showcasing his diverse range of expertise.

Career Highlights: Throughout his illustrious career, Michael E Lewis has been recognized for his ability to transform innovative ideas into tangible inventions that have revolutionized the way we live and work.

Collaborations: Michael E Lewis has collaborated with leading companies, research institutions, and universities to further develop his inventions and bring them to the market, solidifying his reputation as a visionary inventor.

Conclusion: Michael E Lewis continues to inspire the next generation of inventors with his passion for innovation and his relentless pursuit of turning ideas into reality.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…